First 3-D-printed Drug Approved by FDA

An epilepsy drug that is manufactured with 3-D printing was approved by the FDA, the drugmaker announced.

Spritam, an epilepsy drug that is produced with the technology to make a porous formulation that disintegrates quickly with a sip of liquid, according to Aprecia Pharmaceuticals.

The technology offers the potential to create bespoke drugs based on the specific needs of patients, rather than a 'one product fits all approach' and opens the door to a host of new opportunities.